MedPath
NMPA Approval

Rifapentine Capsules

国药准字H10840004

March 22, 2024

Drug Information

利福喷丁胶囊

明佳欣

胶囊剂

0.15g

化学药品

March 22, 2024

Company Information

Applicant Company

成都市温江区成都海峡两岸科技产业开发园青啤大道1069号

Manufacturing Company

成都市温江区成都海峡两岸科技产业开发园青啤大道1069号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利福喷丁胶囊 - NMPA 批准文号 | MedPath